共 751 条
[11]
Lustberg MB(2012)Targeted cellular ionic calcium chelation by oxalates: implications for the treatment of tumor cells Cancer Cell Int 154 1749-25
[12]
Leblanc AF(2017)Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial—CALGB/alliance 170601 Eur J Cancer Care (Engl) 32 997-140
[13]
Sprowl JA(2013)An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways Pain 71 19-851
[14]
Alberti P(2014)Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance) J Clin Oncol 12 e0186250-128
[15]
Chiorazzi A(2014)Prevention and treatment of chemotherapy-induced peripheral neuropathy Am J Health Pharm 120 127-3056
[16]
Arnold WD(2017)Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: phenotypic and genotypic insights PLoS ONE 71 843-11204
[17]
Gibson AA(2017)The molecular genetics of chemotherapy–induced peripheral neuropathy: a systematic review and meta-analysis Crit Rev Oncol Hematol 349 124-2381
[18]
Nishida K(2013)Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer Cancer Chemother Pharmacol 35 85-6368
[19]
Takeuchi K(2015)Candidate pathway-based genetic association study of platinum and platinum–taxane related toxicity in a cohort of primary lung cancer patients J Neurol Sci 12 3050-3577
[20]
Hosoda A(2016)Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-sma Chin J Cancer 110 11199-591